Ernesto Bertarelli Net Worth

Ernesto Bertarelli has an estimated net worth of $11.5 billion, according to Forbes Real-Time Billionaires, Ernesto Bertarelli profile (figures as of October 20, 2026). That is up from $8 billion in 2019.

Ernesto Bertarelli is a Swiss businessman known for biotech, investing, and sailing. He became CEO of Serono in 1996 and inherited the company with his sister Dona in 1998 after their father's death. Under their leadership, Serono leaned further into biotechnology. The company was known for Rebif, a multiple sclerosis drug, along with treatments for infertility and growth hormone deficiency. That business success turned Bertarelli into one of Switzerland's best-known healthcare fortunes.

A major turning point came in 2007, when the family sold Serono to Merck for over $13 billion. Before that deal, Ernesto and Dona had expanded the company to $2.4 billion in revenues. Much of the family's wealth is now managed through B-Flexion Group, which invests in areas including drug companies and commercial real estate in London. Outside business, he is also known in sailing. His Team Alinghi won the America's Cup in 2003 and 2007.

How Ernesto Bertarelli built his fortune

Bertarelli's wealth started with Serono, the biotech company he inherited with his sister in 1998. He had already become CEO in 1996, and he helped shift the business more deeply toward biotechnology. Serono's products included Rebif, used for multiple sclerosis, as well as treatments tied to infertility and growth hormone deficiency. The family's big payday came when they sold the company to Merck in 2007 for over $13 billion.

After the Serono sale, the family put much of its capital into B-Flexion, its investment group. The firm has holdings that range from commercial real estate in London to healthcare and drug businesses. Background details also note specialist investment partnerships in real estate, technology, hedge funds, and life sciences. Alongside that business activity, Bertarelli co-chairs the Bertarelli Foundation with Dona, focusing on marine conservation and life sciences research.

Forbes net worth snapshot

Forbes has tracked Bertarelli in healthcare, with wealth tied to biotech and investments. Its estimates moved from $8 billion in 2019 and 2020 to $8.6 billion in 2021, then $8.5 billion in 2022. The next 2 years showed a bigger rise, reaching $9.4 billion in 2023 and $11.2 billion in 2024. Those changes fit the picture of a fortune built first in biotech, then managed through a broad investment platform.

The most recent Forbes numbers put him at $11.5 billion on the 2025 World's Billionaires List, $11.6 billion on the 2026 list, and $11.5 billion on Forbes' real-time billionaires tracker as of October 20, 2026. Forbes ties his wealth to biotech and investments rather than a single operating company today. That makes sense given the family's long-running shift from Serono into B-Flexion's mix of real estate, life sciences, and other investment holdings.